Introduction
These terms and conditions ("Agreement") apply between you, the User of this Website (including any sub‑domains, unless expressly excluded by their own terms and conditions), and PHARMAFOOTPATH LTD ("PharmaFootpath", "we", "our" or "us"), the owner and operator of this Website.
Please read these terms and conditions carefully, as they affect your legal rights. Your agreement to comply with and be bound by this Agreement is deemed to occur upon your first use of the Website. If you do not agree to be bound by this Agreement, you must stop using the Website immediately.
In this Agreement, User or Users means any third party that accesses the Website and is not either (i) employed by PharmaFootpath and acting in the course of their employment or (ii) engaged as a consultant or otherwise providing services to PharmaFootpath and accessing the Website in connection with the provision of such services.
You must be at least 18 years of age to use this Website. By using the Website and agreeing to this Agreement, you represent and warrant that you are at least 18 years of age.
1.) Ownership. All content included on the Website, unless uploaded by Users, is the property of PharmaFootpath, our affiliates or other relevant third parties. In this Agreement, Content means any text, graphics, images, audio, video, software, data compilations, page layout, underlying code and software and any other form of information capable of being stored in a computer that appears on or forms part of this Website, including any such content uploaded by Users. Such Content is protected by copyright, trademarks, database rights and other intellectual‑property rights. Nothing on this site shall be construed as granting, by implication, estoppel, or otherwise, any licence or right to use any trademark, logo or service mark displayed on the site without the owner's prior written permission.
2.) Internal‑use licence. For your own internal business purposes only you may: (a) retrieve, display and view the Content on screens within your organisation; (b) download and store reasonable extracts of the Content on your internal systems; and (c) print or circulate reasonable extracts internally, in each case provided that such use complies with clause 3 (Licence Grant & Scope) and any attribution requirements contained therein. Any other reproduction, modification, distribution or commercial exploitation of the Content requires the prior written permission of PharmaFootpath.
3.) Licence grant. Subject to your compliance with this Agreement, PharmaFootpath grants you a limited, non‑exclusive, non‑transferable, revocable, worldwide licence to access and use the Service and the Data solely for your own internal business purposes.
a.) Restrictions. Except as expressly permitted in this clause, you must not: (i) copy, distribute, sell, sublicense, or otherwise make the Data or Service available to any third party; (ii) incorporate the Data into any product or service for external commercial distribution; (iii) use the Data to train or develop artificial‑intelligence or machine‑learning models; (iv) remove or alter any proprietary notices, watermarking, or source attributions contained in the Data; (v) attempt to gain unauthorised access to any portion of the Service; (vi) perform or attempt any text‑or‑data‑mining, scraping, web‑crawling or other automated extraction of the Data or Website, except where such activity cannot be lawfully restricted under mandatory law; (vii) circumvent, disable or otherwise interfere with any technological protection measures, digital‑rights‑management (DRM) systems, API keys, rate‑limits or access‑controls deployed by PharmaFootpath in connection with the Service; or (viii) fail to display “Source: PharmaFootpath” (or such other attribution as we may reasonably require) on any internal reports, dashboards or analyses that incorporate the Data, where technically and commercially practicable.
b.) Audit. You agree to keep reasonable records of use and to provide, upon at least ten (10) business days’ written notice, information necessary for PharmaFootpath to verify compliance with this Agreement.
4.) Use of AI. PharmaFootpath may employ third‑party artificial‑intelligence services—including, but not limited to, OpenAI’s GPT models—to assist with background research on publicly available corporate information.
a.) No Customer Data Transmitted. PharmaFootpath will not transmit, upload, or otherwise disclose any Customer Confidential Information or personal data to such AI services.
b.) Outputs. AI‑assisted outputs are provided “AS IS”, solely to support the Service; PharmaFootpath does not guarantee their accuracy, completeness, or fitness for any particular purpose.
c.) Compliance. PharmaFootpath remains responsible for the AI service providers’ compliance with all applicable law and the confidentiality obligations in this Agreement.
5.) You may not use the Website for any of the following purposes: a.) in any way which causes, or may cause, damage to the Website or interferes with any other person's use or enjoyment of the Website; b.) in any way which is harmful, unlawful, illegal, abusive, harassing, threatening or otherwise objectionable or in breach of any applicable law, regulation, governmental order; c.) making, transmitting or storing electronic copies of Content protected by copyright without the permission of the owner.
6.) You must ensure that the details provided by you on registration or at any time are correct and complete.
7.) You must inform us immediately of any changes to the information that you provide when registering by updating your personal details so we can communicate with you effectively.
8.) We may suspend or cancel your registration with immediate effect for any reasonable purposes or if you breach this Agreement.
9.) You may cancel your registration at any time by informing us in writing to the address at the end of this Agreement. If you do so, you must immediately stop using the Website. Cancellation or suspension of your registration does not affect any statutory rights.
10.) When you register on this Website, you will be asked to create a password, which you must keep confidential and not disclose or share with anyone.
11.) If we have reason to believe that there is or is likely to be any misuse of the Website or breach of security, we may require you to change your password or suspend your account.
12.) This Website may contain links to other sites. Unless expressly stated, these sites are not under the control of PharmaFootpath or that of our affiliates.
13.) We assume no responsibility for the content of such websites and disclaim liability for any and all forms of loss or damage arising out of the use of them.
14.) The inclusion of a link to another site on this Website does not imply any endorsement of the sites themselves or of those in control of them.
15.) Use of the Website is also governed by our Privacy Policy and Cookies Policy, which are incorporated into this Agreement by this reference. To view the Privacy Policy and Cookies Policy, please visit www.pharmafootpath.com/privacy and www.pharmafootpath.com/cookies.
16.) Any online facilities, tools, services or information that PharmaFootpath makes available through the Website (the Service) are provided "as is" and on an "as available" basis. We give no warranty that the Service will be free of defects and/or faults. To the maximum extent permitted by law, we provide no warranties (express or implied) of fitness for a particular purpose, accuracy of information, compatibility and satisfactory quality. PharmaFootpath is under no obligation to update information on the Website.
17.) Whilst PharmaFootpath uses reasonable endeavours to ensure that the Website is secure and free of errors, viruses and other malware, we give no warranty or guarantee in that regard and all Users take responsibility for their own security, that of their personal details and their computers.
18.) PharmaFootpath accepts no liability for any disruption or non‑availability of the Website.
19.) PharmaFootpath reserves the right to alter, suspend or discontinue any part (or the whole of) the Website including, but not limited to, any products and/or services available. This Agreement shall continue to apply to any modified version of the Website unless it is expressly stated otherwise.
20.) Uptime commitment. PharmaFootpath will use commercially reasonable efforts to make the Service available at least 99.5 % of the time in each calendar month, excluding (i) scheduled maintenance notified at least twenty‑four (24) hours in advance and not exceeding four (4) hours per calendar month, and (ii) any unavailability caused by circumstances beyond PharmaFootpath's reasonable control.
a.) Service credits. If availability falls below this target in a given month and you pay subscription fees for the Service, your sole and exclusive remedy will be a service‑credit equal to five percent (5 %) of the pro‑rated monthly fee for each full one‑percent (1 %) below the uptime target, up to a maximum credit of twenty‑five percent (25 %) of that month’s fee.
b.) Support hours. Email support is available Monday–Friday 09:00–17:00 UK time (excluding UK public holidays) via support@pharmafootpath.com. PharmaFootpath will use reasonable endeavours to acknowledge support requests within one (1) business day.
c.) Sole remedy. Service‑credits constitute your sole and exclusive remedy for any failure by PharmaFootpath to meet the uptime commitment.
21.) Confidential Information. Each party ("Recipient") shall keep in strict confidence all information of a confidential nature ("Confidential Information") disclosed by the other party ("Discloser") that is marked or otherwise identified as confidential, or that a reasonable person would understand to be confidential given the nature of the information and the circumstances of disclosure.
a.) Exclusions. Confidential Information does not include information that (i) is or becomes public other than through a breach of this clause; (ii) was lawfully known to the Recipient before disclosure; (iii) is received from a third party who did not acquire or disclose the same in breach of any legal obligation; or (iv) is independently developed without reference to the Confidential Information.
b.) Permitted disclosure. The Recipient may disclose Confidential Information to its employees, officers, consultants, agents, and professional advisers who need to know such information for the purpose of exercising the Recipient’s rights or carrying out its obligations under this Agreement and who are bound by confidentiality obligations no less onerous than those in this clause.
c.) Survival. The obligations in this clause survive for three (3) years after termination or expiry of this Agreement, or indefinitely in the case of trade secrets.
22.) Each party shall comply with all applicable data‑protection and privacy legislation in force from time to time, including the UK GDPR and the Data Protection Act 2018.
a.) Roles. Where PharmaFootpath processes any personal data on behalf of the User, PharmaFootpath acts as processor and the User as controller. PharmaFootpath shall: – process such personal data only on the documented instructions of the User; – implement appropriate technical and organisational measures to protect personal data against unauthorised or unlawful processing and accidental loss, destruction or damage; – ensure that individuals authorised to process the personal data are subject to confidentiality obligations; – not transfer personal data outside the UK (or, where applicable, the EEA) unless a legally‑valid transfer mechanism (e.g. UK IDTA or SCCs) is in place; – promptly notify the User of any personal‑data breach involving the User’s personal data; and – delete or return personal data upon termination of the Agreement, unless retention is required by law.
b.) No personal data to AI services. PharmaFootpath confirms that it does not send or upload any personal data provided by the User to OpenAI or any other third‑party AI service.
c.) Independent‑controller data. For personal data collected by PharmaFootpath for its own purposes (e.g., account‑management, billing, analytics), PharmaFootpath acts as independent controller and processes such data in accordance with its Privacy Policy.
23.) Information and medical‑decision disclaimer. All Content and Data made available through the Service are provided for information purposes only and are not intended to be used for diagnosing, treating, curing or preventing any disease, nor for making clinical or regulatory decisions. You are solely responsible for verifying any Data with the competent authorities or source country before relying on it. PharmaFootpath does not warrant the accuracy, completeness, or timeliness of any Data and shall not be liable for any errors or omissions.
24.) Liability cap. Subject to clause 25, PharmaFootpath's total aggregate liability, whether in contract, tort (including negligence), breach of statutory duty or otherwise, arising out of or in connection with this Agreement shall not exceed (i) one hundred thousand pounds sterling (£100,000) or (ii) the total fees (if any) actually paid by you to PharmaFootpath in the twelve (12) months immediately preceding the event giving rise to the liability—whichever is greater.
25.) Excluded losses. PharmaFootpath shall not be liable for any (a) loss of profits, revenue, business, goodwill, or anticipated savings; (b) loss or corruption of data; or (c) special, indirect or consequential loss. Nothing in this Agreement limits or excludes liability for death or personal injury caused by negligence, fraud, or any other liability that cannot be excluded under applicable law.
26.) Neither party shall be in breach of this Agreement nor liable for delay in performing, or failure to perform, any of its obligations if such delay or failure results from events, circumstances or causes beyond its reasonable control, including but not limited to acts of God, flood, epidemic or pandemic, fire, strike, lock‑out, civil commotion, war, terrorist act, interruption or failure of utilities or telecommunications, or governmental restrictions. The affected party shall use reasonable endeavours to mitigate the effect of the force‑majeure event and, if the event continues for more than thirty (30) consecutive days, either party may terminate this Agreement on written notice.
27.) This Agreement and any dispute or claim (including non‑contractual disputes or claims) shall be governed by and construed in accordance with the laws of England and Wales.
a.) Arbitration option. Either party may elect that any dispute be finally resolved by arbitration under the LCIA Rules, which Rules are deemed incorporated by reference. The seat of arbitration shall be London, England; the tribunal shall consist of one arbitrator; and the language of the arbitration shall be English.
b.) Court jurisdiction. If no party has elected arbitration in accordance with sub‑clause 27 a, the courts of England and Wales shall have exclusive jurisdiction to settle the dispute.
c.) Language. The English‑language version of this Agreement prevails over any translation.
28.) Assignment. You may not assign, transfer or sub‑contract any of your rights or obligations under this Agreement without PharmaFootpath’s prior written consent. PharmaFootpath may assign or transfer its rights and obligations provided such assignment does not materially prejudice your rights.
Variation. We reserve the right to vary this Agreement from time to time. The updated version will be effective when posted on the Website, and your continued use of the Website after any changes constitutes acceptance of the new terms.
Entire agreement. This Agreement, together with the Privacy Policy and Cookies Policy, constitutes the entire agreement between the parties and supersedes all prior discussions, arrangements or agreements relating to its subject matter.
Third‑party rights. The Contracts (Rights of Third Parties) Act 1999 does not apply to this Agreement; no third party has the right to enforce any of its terms.
Severability. If any provision of this Agreement is found invalid or unenforceable by a court of competent jurisdiction, that provision shall be severed and the remainder of the Agreement shall continue in full force.
Waiver. No failure or delay by either party to exercise any right or remedy shall constitute a waiver of that or any other right or remedy.
29.) PharmaFootpath Ltd is a company incorporated in England and Wales with registered number 14504862 and registered address Portland House, 113-116 Bute Street, Cardiff, Wales, CF10 5EQ. You can contact PharmaFootpath by email at hello@pharmafootpath.com.
30.) © PharmaFootpath Ltd 2025. Source: PharmaFootpath. All rights reserved.
Version 2
Published 2025-07-03